Modeling the dynamics of disease states in depression

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Demic, Selver ^a,b,c   Cheng, Sen ^a,b,c  

^a International Graduate School of Neuroscience   (Germany)

^b Mercator Research Group Structure of Memory   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COGNITIVE THERAPY; COMPUTER SIMULATION; CRITERION VARIABLE; DATA ANALYSIS SOFTWARE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DSM-IV-TR; FINITE STATE MACHINE; HUMAN; LIFESTYLE MODIFICATION; MAJOR DEPRESSION; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MATHEMATICAL VARIABLE; MOLECULAR DYNAMICS; OUTCOME ASSESSMENT; PREDICTION; PROBABILITY; RECURRENT DISEASE; STATISTICAL ANALYSIS; BIOLOGICAL MODEL; PATHOPHYSIOLOGY; RISK FACTOR; TIME;

DEPRESSIVE DISORDER, MAJOR; DISEASE PROGRESSION; HUMANS; MODELS, BIOLOGICAL; RECURRENCE; RISK FACTORS; TIME FACTORS;

EID: 84908130826     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110358     Document Type: Article

References (87)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders IV Edition Text Revision (DSM IV TR). Washington DC, USA: APA.
2. Blazer DG, Kessler RC, McGonagle KA, Swartz MS (1994) The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. The American journal of psychiatry 151: 979-986.
3. Hasin DS, Goodwin RD, Stinson FS, Grant BF (2005) Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Archives of general psychiatry 62: 1097-1106. doi:10.1001/archpsyc.62.10.1097.
4. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, et al. (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of general psychiatry 62: 593-602. doi:10.1001/archpsyc.62.6.593.
5. Hasler G (2010) Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World psychiatry: official journal of the World Psychiatric Association (WPA) 9: 155-161.
6. Angst F, Stassen HH, Clayton PJ, Angst J (2002) Mortality of patients with mood disorders: follow-up over 34-38 years. Journal of affective disorders 68: 167-181.
7. Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349: 1436-1442. doi:10.1016/S0140-6736(96)07495-8.
8. Weissman MM (1996) Cross-National Epidemiology of Major Depression and Bipolar Disorder. JAMA: The Journal of the American Medical Association 276: 293. doi:10.1001/jama.1996.03540040037030.
9. Nolen-Hoeksema S (2001) Gender Differences in Depression. Current Directions in Psychological Science 10: 173-176. doi:10.1111/1467-8721.00142.
10. Kessler R, Berglund P, Demler O, Jin R, Koretz D, et al. (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA: the journal of the American Medical Association 289: 3095-3105. doi: doi: 10.1001/jama.289.23.3095.
11. Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, et al. (2003) The economic burden of depression in the United States: how did it change between 1990 and 2000? The Journal of clinical psychiatry 64: 1465-1475.
12. Murray CJ, Lopez AD (1996) Evidence-based health policy-lessons from the Global Burden of Disease Study. Science (New York, NY) 274: 740-743.
13. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, et al. (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of general psychiatry 51: 8-19. doi: 10.1001/archpsyc.1994.03950010008002.
14. Kessler RC, Bromet EJ (2013) The epidemiology of depression across cultures. Annual review of public health 34: 119-138. doi:10.1146/annurev-publhealth-031912-114409.
15. Nestler E, Barrot M, DiLeone R, Eisch A, Gold S, et al. (2002) Neurobiology of depression. Neuron 34: 13-25.
16. Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. The American journal of psychiatry 157: 1552-1562.
17. Flint J, Kendler KS (2014) The Genetics of Major Depression. Neuron 81: 484-503. doi:10.1016/j.neuron.2014.01.027.
18. Kendler KS, Gatz M, Gardner CO, Pedersen NL (2006) A Swedish national twin study of lifetime major depression. The American journal of psychiatry 163: 109-114. doi:10.1176/appi.ajp.163.1.109.
19. Monroe SM, Simons AD (1991) Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychological bulletin 110: 406-425.
20. Hornung OP, Heim CM (2014) Gene-Environment Interactions and Intermediate Phenotypes: Early Trauma and Depression. Frontiers in endocrinology 5: 14. doi:10.3389/fendo.2014.00014.
21. Belmaker RH, Agam G (2008) Major depressive disorder. The New England journal of medicine 358: 55-68. doi: 10.1056/nejmra073096.
22. Lopez-Munoz F, Alamo C (2009) Monoaminergic Neurotransmission: The History of the Discovery of Antidepressants from 1950s Until Today. Current Pharmaceutical Design 15: 1563-1586. doi:10.2174/138161209788168001.
23. Morilak DA, Frazer A (2004) Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. The international journal of neuropsychopharmacology/ official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 7: 193-218. doi :10.1017/S1461145704004080.
24. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (New York, NY) 301: 805-809. doi: 10.1126/science.1083328.
25. Thompson C (2002) Onset of action of antidepressants: results of different analyses. Human psychopharmacology 17 Suppl 1: S27-32. doi:10.1002/hup.386.
26. Stassen HH, Delini-Stula A, Angst J (1993) Time course of improvement under antidepressant treatment: A survival-analytical approach. European Neuropsychopharmacology 3: 127-135. doi:10.1016/0924-977X(93)90264-M.
27. Segman RH, Gorfine M, Lerer B, Shapira B (1995) Onset and time course of antidepressant action: psychopharmacological implications of a controlled trial of electroconvulsive therapy. Psychopharmacology 119: 440-448. doi:10.1007/BF02245860.
28. Quitkin FM, Stewart JW, McGrath PJ, Nunes E, Ocepek-Welikson K, et al. (1993) Further evidence that a placebo response to antidepressants can be identified. The American journal of psychiatry 150: 566-570.
29. Machado-Vieira R, Salvadore G, Luckenbaugh DA, Manji HK, Zarate CA (2008) Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. The Journal of clinical psychiatry 69: 946-958.
30. Macedo-Soares MB de, Moreno RA, Rigonatti SP, Lafer B (2005) Efficacy of electroconvulsive therapy in treatment-resistant bipolar disorder: a case series. The journal of ECT 21: 31-34.
31. Ruhé H, Huyser J, Swinkels J, Schene A (2006) Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review. The Journal of clinical psychiatry 67: 1836-1855.
32. Walsh BT, Seidman SN, Sysko R, Gould M (2002) Placebo Response in Studies of Major Depression. JAMA 287: 1840. doi:10.1001/jama.287.14.1840.
33. Anderson IM, Tomenson BM (1994) The efficacy of selective serotonin reuptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. Journal of psychopharmacology (Oxford, England) 8: 238-249. doi:10.1177/026988119400800407.
34. Fava M (2000) New approaches to the treatment of refractory depression. The Journal of clinical psychiatry 61 Suppl 1: 26-32.
35. Nelson JC (1998) Treatment of antidepressant nonresponders: augmentation or switch? The Journal of clinical psychiatry 59 Suppl 1: 35-41.
36. Kirsch I, SG (1998) Listening to prozac but hearing placebo: a meta-analysis of antidepressant medicatione. Prevention and treatment article 0002a I, article.
37. Ellis HC, Ottaway SA, Varner LJ, Becker AS, Moore BA (1997) Emotion, motivation, and text comprehension: the detection of contradictions in passages. Journal of experimental psychology General 126: 131-146.
38. Thase ME (1999) How should efficacy be evaluated in randomized clinical trials of treatments for depression? The Journal of clinical psychiatry 60 Suppl 4: 23-31; discussion 32.
39. Perry R, Cassagnol M (2009) Desvenlafaxine: a new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder. Clinical therapeutics 31 Pt 1: 1374-1404. doi:10.1016/j.clinthera.2009.07.012.
40. Nemeroff CB, Heim CM, Thase ME, Klein DN, Rush a J, et al. (2003) Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proceedings of the National Academy of Sciences of the United States of America 100: 14293-14296. doi:10.1073/pnas.2336126100.
41. Beck AT (1976) Cognitive therapy and the emotional disorders.
42. Moore MT, Fresco DM (2012) Depressive realism: a meta-analytic review. Clinical psychology review 32: 496-509. doi:10.1016/j.cpr.2012.05.004.
43. DeRubeis RJ, Crits-Christoph P (1998) Empirically supported individual and group psychological treatments for adult mental disorders. Journal of consulting and clinical psychology 66: 37-52.
44. Kennedy SH (2008) Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues in clinical neuroscience 10: 271-277.
45. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, et al. (1991) Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of general psychiatry 48: 851-855.
46. Eaton W, Shao H, Nestadt G, Lee HB, Lee BH, et al. (2008) Population-based study of first onset and chronicity in major depressive disorder. Archives of general psychiatry 65: 513-520. doi: 10.1001/archpsyc.65.5.513.
47. Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman ATF (2010) Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta psychiatrica Scandinavica 122: 184-191. doi:10.1111/j.1600-0447.2009.01519.x.
48. Torpey DC, Klein DN (2008) Chronic depression: update on classification and treatment. Current psychiatry reports 10: 458-464.
49. Sahay A, Hen R (2007) Adult hippocampal neurogenesis in depression. Nature neuroscience 10: 1110-1115. doi:10.1038/nn1969.
50. Cheng S (2013) The CRISP theory of hippocampal function in episodic memory. Frontiers in neural circuits 7: 88. doi:10.3389/fncir.2013.00088.
51. Spijker J, de Graaf R, Bijl R, Beekman A, Ormel J, et al. (2002) Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). The British journal of psychiatry: the journal of mental science 181: 208-213. doi:10.1192/bjp.181.3.208.
52. Furukawa TA, Kitamura T, Takahashi K (2000) Time to recovery of an inception cohort with hitherto untreated unipolar major depressive episodes. The British journal of psychiatry: the journal of mental science 177: 331-335.
53. Angst J, Preisig M (1995) Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweizer Archiv für Neurologie und Psychiatrie (Zurich, Switzerland: 1985) 146: 5-16.
54. Keller MB, Shapiro RW, Lavori PW, Wolfe N (1982) Recovery in major depressive disorder: analysis with the life table and regression models. Archives of general psychiatry 39: 905-910.
55. Solomon DA, Keller MB, Leon AC, Mueller TI, Shea MT, et al. (1997) Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Archives of general psychiatry 54: 1001-1006.
56. Mueller TI, Keller MB, Leon AC, Solomon DA, Shea MT, et al. (1996) Recovery after 5 years of unremitting major depressive disorder. Archives of general psychiatry 53: 794-799.
57. Beck JS (1995) Cognitive therapy: Basics and Beyond. New York: Guilford Press.
58. Hollon SD, Thase ME, Markowitz JC (2002) Treatment and Prevention of Depression. Psychological Science in the Public Interest 3: 39-77. doi:10.1111/ 1529-1006.00008.
59. Jarrett RB, Schaffer M, McIntire D, Witt-Browder A, Kraft D, et al. (1999) Treatment of atypical depression with cognitive therapy or phenelzine: a doubleblind, placebo-controlled trial. Archives of general psychiatry 56: 431-437.
60. Hollon SD, DeRubeis RJ, Evans MD, Wiemer MJ, Garvey MJ, et al. (1992) Cognitive therapy and pharmacotherapy for depression. Singly and in combination. Archives of general psychiatry 49: 774-781.
61. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO (2005) Exercise treatment for depression: efficacy and dose response. American journal of preventive medicine 28: 1-8. doi:10.1016/j.amepre.2004.09.003.
62. Blumenthal JA, Babyak MA, Doraiswamy PM, Watkins L, Hoffman BM, et al. (2007) Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosomatic medicine 69: 587-596. doi:10.1097/PSY.0-b013e318148c19a.
63. Martinsen EW (2008) Physical activity in the prevention and treatment of anxiety and depression. Nordic journal of psychiatry 62 Suppl 4: 25-29. doi:10.1080/08039480802315640.
64. Siegle G, Thompson W, Carter C, Steinhauer S, Thase M (2007) Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biological psychiatry 61: 198-209. doi: doi: 10.1016/j.biopsych.2006.05.048.
65. Surguladze S, Brammer M, Keedwell P, Giampietro V, Young A, et al. (2005) A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biological psychiatry 57: 201-209. doi: 10.1016/j.biopsych.2004.10.028.
66. Drevets W, Bogers W, Raichle M (2002) Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology 12: 527-544.
67. Hamilton P, Gotlib I (2008) Neural substrates of increased memory sensitivity for negative stimuli in major depression. Biological psychiatry 63: 1155-1162. doi: 10.1016/j.biopsych.2007.12.015.
68. Ramel W, Goldin P, Eyler L, Brown G, Gotlib I, et al. (2007) Amygdala reactivity and mood-congruent memory in individuals at risk for depressive relapse. Biological psychiatry 61: 231-239. doi: 10.1016/j.biopsych.2006.05.004.
69. Widiger TA, Samuel DB (2005) Diagnostic categories or dimensions? A question for the Diagnostic And Statistical Manual Of Mental Disorders-fifth edition. Journal of abnormal psychology 114: 494-504. doi:10.1037/0021-843X.114.4.494.
70. Edwards VJ, Holden GW, Felitti VJ, Anda RF (2003) Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. The American journal of psychiatry 160: 1453-1460.
71. Chapman DP, Whitfield CL, Felitti VJ, Dube SR, Edwards VJ, et al. (2004) Adverse childhood experiences and the risk of depressive disorders in adulthood. Journal of affective disorders 82: 217-225. doi:10.1016/j.jad.2003.12.013.
72. Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB (2008) The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology 33: 693-710. doi:10.1016/j.psyneuen.2008.03.008.
73. Felitti VJ, Anda RF, Nordenberg D, Williamson DF, Spitz AM, et al. (1998) Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. American journal of preventive medicine 14: 245-258.
74. Gladstone GL, Parker GB, Mitchell PB, Malhi GS, Wilhelm K, et al. (2004) Implications of childhood trauma for depressed women: an analysis of pathways from childhood sexual abuse to deliberate self-harm and revictimization. The American journal of psychiatry 161: 1417-1425. doi:10.1176/appi.ajp. 161.8.1417.
75. Bernet CZ, Stein MB (1999) Relationship of childhood maltreatment to the onset and course of major depression in adulthood. Depression and anxiety 9: 169-174.
76. Zlotnick C, Mattia J, Zimmerman M (2001) Clinical features of survivors of sexual abuse with major depression. Child abuse & neglect 25: 357-367.
77. Zlotnick C, Ryan CE, Miller IW, Keitner GI (1995) Childhood abuse and recovery from major depression. Child abuse & neglect 19: 1513-1516.
78. Hayden EP, Klein DN (2001) Outcome of dysthymic disorder at 5-year followup: the effect of familial psychopathology, early adversity, personality, comorbidity, and chronic stress. The American journal of psychiatry 158: 1864-1870.
79. Kaplan MJ, Klinetob NA (2000) Childhood emotional trauma and chronic posttraumatic stress disorder in adult outpatients with treatment-resistant depression. The Journal of nervous and mental disease 188: 596-601.
80. Geddes JR, Carney SM, Davies C, Furukawa T a, Kupfer DJ, et al. (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361: 653-661. doi:10.1016/S0140-6736(03)12599-8.
81. Furukawa T a (2000) Time to recovery of an inception cohort with hitherto untreated unipolar major depressive episodes. The British Journal of Psychiatry 177: 331-335. doi:10.1192/bjp.177.4.331.
82. Mueller TI, Leon a C, Keller MB, Solomon D a, Endicott J, et al. (1999) Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. The American journal of psychiatry 156: 1000-1006.
83. Keller MB, Lavori PW, Rice J, Coryell W, Hirschfeld RM (1986) The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up. The American journal of psychiatry 143: 24-28.
84. Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De Graaf R, et al. (2003) The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. International journal of methods in psychiatric research 12: 3-21.
85. Consensus Development Panel (1985) NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Consensus Development Panel. American Journal of Psychiatry 142: 469-476.
86. Luty SE, Carter JD, McKenzie JM, Rae AM, Frampton CMA, et al. (2007) Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. The British journal of psychiatry: the journal of mental science 190: 496-502. doi:10.1192/bjp.bp.106.024729.
87. Möller HJ, Müller H, Volz HP (1996) How to assess the onset of antidepressant effect: comparison of global ratings and findings based on depression scales. Pharmacopsychiatry 29: 57-62. doi:10.1055/s-2007-979545.